Sphera Global Healthcare Fund

Summary

The main department of described VC is located in the Tel Aviv. The fund was located in Asia if to be more exact in Israel.

For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Orchard Therapeutics, Deciphera Pharmaceuticals Among the most successful fund investment fields, there are Biotechnology, Genetics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups.

This organization was formed by Mori Arkin. We also calculated 3 valuable employees in our database.

The fund is constantly included in less than 2 deals per year. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2018. This Sphera Global Healthcare Fund works on 71 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2017. Deals in the range of 50 - 100 millions dollars are the general things for fund.

The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Sphera Global Healthcare Fund, startups are often financed by F-Prime Capital, UCL Technology Fund, Temasek Holdings. The meaningful sponsors for the fund in investment in the same round are Venrock, Viking Global Investors, Temasek Holdings. In the next rounds fund is usually obtained by Oxford Finance LLC.